Long-term effects of faecal microbiota transplantation
Official title: Long Term Safety and Efficacy of Faecal Microbiota Transplantation: a Nationwide Obeservational Study
Run by Joint Authority for Päijät-Häme Social and Health Care · NCT03732131 · Data updated 2026-11-12
This study looks at the long-term effects of stool transplants in adults who are getting the treatment for repeated Clostridium difficile infections or other health issues.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Joint Authority for Päijät-Häme Social and Health Care Academic / other |
| Locations | 1 site (Lahti) |
| Status | Recruiting |
| Started | October 18, 2018 |
| Main results expected | December 2021 |
| Study ends | January 15, 2029 |
| Registry record updated | February 17, 2020 |
| Trial ID | NCT03732131 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who are undergoing faecal microbiota transplantation for recurrent Clostridium difficile infection or other medical conditions.
✕Probably not a fit
Patients who are under 18 years old or unable to provide written consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to observe the long-term effects of faecal microbiota transplantation (FMT) in patients over 18 years old who are receiving FMT for recurrent Clostridium difficile infection or other medical conditions. Participants will provide written consent and will be monitored for outcomes and potential side effects through blood and fecal samples for one year, with follow-up questionnaires extending up to ten years post-transplant. The study is observational and does not involve any specific interventions.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term safety and efficacy of faecal microbiota transplantation.
How similar studies have gone: Other studies have shown promising results regarding the efficacy of faecal microbiota transplantation, making this approach a relevant area of investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \> 18 years age * receiving FMT for rCDI or any other madical condition * written consent * Not included in other FMT trials Exclusion Criteria: * Unable to provide written consent * \< 18 years age * Included in other FMT-trial
Where it's running
-
Joint Authority for Päijät-Häme Social and Health Care
Lahti, Finland Recruiting
Study contacts
- Study coordinator: Perttu Lahtinen, MD
- Email: perttu.lahtinen@phhyky.fi
- Phone: +358-3-819 11
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rehabilitation for stroke patients using nature-based therapies
This study tests if nature-based rehabilitation can help people who have recently had a stroke recover better than those who only do light physical activity.
-
Nature-based therapies for stroke rehabilitation
This study tests if spending time in nature during stroke rehabilitation helps patients recover better than traditional indoor therapy.
-
Optimizing short stay surgery for colorectal patients
This study tests how laparoscopic colorectal surgery affects heart rate changes in patients to see if it can help improve recovery and reduce complications.
-
Group rehabilitation for patients with chronic fatigue syndrome
This study is testing a group therapy program to see if it can help people with chronic fatigue syndrome feel better and manage their illness more effectively.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.